Trial Profile
A trial to study the heart rate variability in major depressive disorder and after antidepressant treatment with agomelatine and paroxentine
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 29 Jun 2016
Price :
$35
*
At a glance
- Drugs Agomelatine (Primary) ; Paroxetine (Primary)
- Indications Major depressive disorder
- Focus Therapeutic Use
- Acronyms TAISDA
- 29 Jun 2016 New trial record